Insight in the safety profile of antidiabetic agents glucagon-like peptide-1 agonists and dipeptidyl peptidase-4 inhibitors in daily practice from the patient perspective.

Anne-Marie van GorpAgnes KantLinda HärmarkPetra van der HorstJudith HendriksSaskia Vorstenbosch

Published in: Pharmacoepidemiology and drug safety (2020)

This study gives insight in the safety profile and ADR characteristics of the new antidiabetic agents. This study provides important knowledge for healthcare professionals in managing ADRs and can be directly applied in consultations in daily practice.

Keyphrases

healthcare
primary care
emergency department
case report
general practice
electronic health record